Alison C Burggren Selected Research

dicyanmethane (malononitrile)

1/2016	Modifiable Risk Factors and Brain Positron Emission Tomography Measures of Amyloid and Tau in Nondemented Adults with Memory Complaints.
7/2012	Self-reported memory impairment and brain PET of amyloid and tau in middle-aged and older adults without dementia.
2/2012	Prediction of cognitive decline by positron emission tomography of brain amyloid and tau.
6/2009	Depression and anxiety symptoms are associated with cerebral FDDNP-PET binding in middle-aged and older nondemented adults.
1/2009	Influence of cognitive status, age, and APOE-4 genetic risk on brain FDDNP positron-emission tomography imaging in persons without dementia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alison C Burggren Research Topics

Disease

9	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 01/2002
5	Amyloid Plaque 01/2016 - 12/2006
4	Dementia (Dementias) 07/2012 - 01/2009
3	Cognitive Dysfunction 02/2012 - 12/2006

Drug/Important Bio-Agent (IBA)

5	Apolipoproteins E (ApoE)IBA 01/2018 - 01/2002
5	dicyanmethane (malononitrile)IBA 01/2016 - 01/2009
5	Amyloid (Amyloid Fibrils)IBA 07/2012 - 12/2006
4	ApolipoproteinsIBA 01/2018 - 11/2010
2	FluorineIBA 02/2012 - 06/2009
1	2- (1- (6- ((2- fluoroethyl)(methyl)amino)- 2- naphthyl)ethylidene)malononitrileIBA 02/2012
1	Biomarkers (Surrogate Marker)IBA 06/2009
1	Apolipoprotein E4IBA 01/2009

Therapy/Procedure

2	Intravenous Injections 06/2009 - 01/2009